<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antibody titers to Epstein-Barr virus (EBV)-associated early antigens (EA) and the <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen (VCA) were determined by ELISA on 263 sera obtained from healthy donors, patients with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>), non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL), <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> (IM), Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), and nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC) </plain></SENT>
<SENT sid="1" pm="."><plain>As expected, most <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients showed markedly elevated anti-VCA IgG and anti-EA IgG antibody titers </plain></SENT>
<SENT sid="2" pm="."><plain>Only one patient in the NHL group (n = 56) consisting of patients with <z:hpo ids='HP_0002665'>lymphomas</z:hpo> other than <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) and hairy-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> (HCL), and 3 patients with HCL (n = 19) had high antibody titers of the IgA class to VCA and EA </plain></SENT>
<SENT sid="3" pm="."><plain>Seventeen out of 48 patients (36%) with CLL had high IgA anti-VCA titers and 10 of these sera (21%) also contained IgA anti-EA </plain></SENT>
<SENT sid="4" pm="."><plain>The geometric mean titer (GMT) of IgA anti-VCA was 2,510, the GMT of IgA anti-EA was 780 </plain></SENT>
<SENT sid="5" pm="."><plain>These antibody titers were about 10 times lower than the corresponding GMT of the NPC patients investigated in this study </plain></SENT>
<SENT sid="6" pm="."><plain>The elevated IgG and IgA antibody titers to VCA and EA in CLL and HCL patients seem to reflect an <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> secondary to the malignant disease leading to reactivation of latent <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The possibility that at least some of these B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are associated with EBV cannot be excluded </plain></SENT>
</text></document>